Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Cox

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
The Journal of Infectious Diseases|June 5, 2008
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndromeIrving Nachamkin, Sean V Shadomy, Anthony P Moran, et al.
The American Journal of Tropical Medicine and Hygiene|December 11, 2012
Capacity building in response to pandemic influenza threats: Lao PDR case studyBounlay Phommasack, Ann Moen, Phengta Vongphrachanh, et al.
MMWR. Morbidity and Mortality Weekly Report|December 16, 2014
Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza seasonCarrie Reed, Inkyu Kevin Kim, James A Singleton, et al.
Journal of Neurochemistry|March 19, 2008
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegenerationJ Ramesh Babu, M Lamar Seibenhener, Junmin Peng, et al.
MMWR. Morbidity and Mortality Weekly Report|October 3, 2014
Update: influenza activity -- United States and worldwide, May 18-September 20, 2014Lenee Blanton, Lynnette Brammer, Sophie Smith, et al.
HGG Advances|May 22, 2023
Genetic and clinical determinants of telomere lengthPatrick Allaire, Jing He, John Mayer, et al.
Vaccine|January 30, 2017
Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015Alan Hampson, Ian Barr, Nancy Cox, et al.
BMC Public Health|April 25, 2020
A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014Yuelong Shu, Ying Song, Dayan Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Genetic Examination of Hematological Parameters in SARS-CoV-2 Infection and COVID-19Bryce Rowland, Quan Sun, Wanjiang Wang, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
The Journal of Infectious Diseases|June 5, 2008
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndromeIrving Nachamkin, Sean V Shadomy, Anthony P Moran, et al.
The American Journal of Tropical Medicine and Hygiene|December 11, 2012
Capacity building in response to pandemic influenza threats: Lao PDR case studyBounlay Phommasack, Ann Moen, Phengta Vongphrachanh, et al.
MMWR. Morbidity and Mortality Weekly Report|December 16, 2014
Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza seasonCarrie Reed, Inkyu Kevin Kim, James A Singleton, et al.
Journal of Neurochemistry|March 19, 2008
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegenerationJ Ramesh Babu, M Lamar Seibenhener, Junmin Peng, et al.
MMWR. Morbidity and Mortality Weekly Report|October 3, 2014
Update: influenza activity -- United States and worldwide, May 18-September 20, 2014Lenee Blanton, Lynnette Brammer, Sophie Smith, et al.
HGG Advances|May 22, 2023
Genetic and clinical determinants of telomere lengthPatrick Allaire, Jing He, John Mayer, et al.
Vaccine|January 30, 2017
Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015Alan Hampson, Ian Barr, Nancy Cox, et al.
BMC Public Health|April 25, 2020
A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014Yuelong Shu, Ying Song, Dayan Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Genetic Examination of Hematological Parameters in SARS-CoV-2 Infection and COVID-19Bryce Rowland, Quan Sun, Wanjiang Wang, et al.
Pageof 7